» Articles » PMID: 21246421

Embryonic Stem Cells: Are Useful in Clinic Treatments?

Overview
Specialties Biochemistry
Physiology
Date 2011 Jan 20
PMID 21246421
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

It is not uncommon to find statements in the social media and even in some scientific journals declaring that embryonic stem cells can be used in human medicine for therapeutic purposes. In our opinion, this statement does not fit the medical reality. To go into this subject in depth, and if possible to clarify it, we reviewed the most recent literature on clinical trials conducted with embryonic stem cells, concluding that up to the present time, there is only one ongoing clinical trial being carried out with these types of cells to treat a small group of patients with spinal cord injury. The results of this trial have still not been published. In conclusion, at present, there is only evidence of one phase I clinical trial conducted with embryonic stem cells, in comparison to the numerous trials conducted with adult stem cells.

Citing Articles

Comparing stem cells, transdifferentiation and brain organoids as tools for psychiatric research.

Bellon A Transl Psychiatry. 2024; 14(1):127.

PMID: 38418498 PMC: 10901833. DOI: 10.1038/s41398-024-02780-8.


Effects of combination treatment with transcranial magnetic stimulation and bone marrow mesenchymal stem cell transplantation or Raf inhibition on spinal cord injury in rats.

Feng S, Wang S, Sun S, Su H, Zhang L Mol Med Rep. 2021; 23(4).

PMID: 33649786 PMC: 7930933. DOI: 10.3892/mmr.2021.11934.


Cell Therapy Augments Functional Recovery Subsequent to Spinal Cord Injury under Experimental Conditions.

Sabapathy V, Tharion G, Kumar S Stem Cells Int. 2015; 2015:132172.

PMID: 26240569 PMC: 4512598. DOI: 10.1155/2015/132172.


Perspectives on the use of stem cells for autism treatment.

Siniscalco D, Bradstreet J, Sych N, Antonucci N Stem Cells Int. 2013; 2013:262438.

PMID: 24222772 PMC: 3810518. DOI: 10.1155/2013/262438.


Cell transplantation for spinal cord injury: a systematic review.

Li J, Lepski G Biomed Res Int. 2013; 2013:786475.

PMID: 23484157 PMC: 3581246. DOI: 10.1155/2013/786475.


References
1.
Amariglio N, Hirshberg A, Scheithauer B, Cohen Y, Loewenthal R, Trakhtenbrot L . Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 2009; 6(2):e1000029. PMC: 2642879. DOI: 10.1371/journal.pmed.1000029. View

2.
Prentice D, Tarne G . Treating diseases with adult stem cells. Science. 2007; 315(5810):328. DOI: 10.1126/science.315.5810.328b. View

3.
Klimanskaya I, Rosenthal N, Lanza R . Derive and conquer: sourcing and differentiating stem cells for therapeutic applications. Nat Rev Drug Discov. 2007; 7(2):131-42. DOI: 10.1038/nrd2403. View

4.
Tabar V, Tomishima M, Panagiotakos G, Wakayama S, Menon J, Chan B . Therapeutic cloning in individual parkinsonian mice. Nat Med. 2008; 14(4):379-81. PMC: 2786166. DOI: 10.1038/nm1732. View

5.
Chidgey A, Layton D, Trounson A, Boyd R . Tolerance strategies for stem-cell-based therapies. Nature. 2008; 453(7193):330-7. DOI: 10.1038/nature07041. View